FGD1 promotes tumor progression and regulates tumor immune response in osteosarcoma via inhibiting PTEN activity

Rationale: Mesenchymal cell-derived osteosarcoma is a rare malignant bone tumor affecting children and adolescents. PTEN down-regulation or function-loss mutation is associated with the aggressive of osteosarcoma. Explicating the regulatory mechanism of PTEN might highlight new targets for improving...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Theranostics
Päätekijät: Wu, Wei, Jing, Doudou, Meng, Zibo, Hu, Binwu, Zhong, Binlong, Deng, Xiangyu, Jin, Xin, Shao, Zengwu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2020
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7052884/
https://ncbi.nlm.nih.gov/pubmed/32194840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.41279
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia